These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38189167)

  • 1. Treatment outcomes in patients with Ewing sarcoma of the spine in a resource-challenged setting: 17-year experience from a single center in India.
    Sasi A; Chitikela S; Ganguly S; Biswas B; Pushpam D; Kumar A; Khan SA; Kumar VS; Kale SS; Biswas A; Barwad A; Mridha AR; Thulkar S; Bakhshi S
    Pediatr Hematol Oncol; 2024 Apr; 41(3):211-223. PubMed ID: 38189167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol.
    Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Sharma DN; Thulkar S; Vishnubhatla S; Pathania S; Bakhshi S
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):722-9. PubMed ID: 24919857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Response Rates and Promising Outcomes of Patients with Relapsed Ewing Sarcoma, Especially in Adolescents and Young Adults Treated on a Novel Hybrid Salvage Chemotherapy Regimen.
    Vijayasekharan K; Ramanathan S; Chinnaswamy G; Prasad M; Gulia A; Janu A; Rekhi B; Ramadwar M; Khanna N; Laskar S; Puranadare N; Bajpai J; Puri A; Banavali S; Vora T
    J Adolesc Young Adult Oncol; 2021 Apr; 10(2):185-192. PubMed ID: 32706630
    [No Abstract]   [Full Text] [Related]  

  • 4. Ewing sarcoma among children 5 years of age or younger: Is it a different disease?
    Nagpal C; Ganguly S; Sasi A; Kumar V; Biswas B; Pushpam D; Kumar A; Agarwala S; Jain V; Dhua A; Yadav DK; Khan SA; Barwad A; Mirdha AR; Biswas A; Thulkar S; Bakhshi S
    Pediatr Blood Cancer; 2024 Nov; 71(11):e31268. PubMed ID: 39138616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult Ewing sarcoma: survival and local control outcomes in 36 patients with metastatic disease.
    Ahmed SK; Robinson SI; Okuno SH; Rose PS; Issa Laack NN
    Am J Clin Oncol; 2014 Oct; 37(5):423-9. PubMed ID: 23388557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in the management of localized Ewing sarcoma in a developing country.
    Totadri S; Bansal D; Rao KLN; Jain R; Saxena AK; Kapoor R; Samujh R; Trehan A
    Pediatr Hematol Oncol; 2020 Oct; 37(7):610-619. PubMed ID: 32558608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group - EWING1.
    Becker RG; Gregianin LJ; Galia CR; Jesus-Garcia Filho R; Toller EA; Badell G; Nakagawa SA; David A; Baptista AM; Yonamime ES; Serafini OA; Penna V; Santos JFC; Brunetto AL;
    BMC Cancer; 2017 Jun; 17(1):420. PubMed ID: 28619077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS).
    Mora J; Castañeda A; Perez-Jaume S; Lopez-Pousa A; Maradiegue E; Valverde C; Martin-Broto J; Garcia Del Muro X; Cruz O; Cruz J; Martinez-Trufero J; Maurel J; Vaz MA; de Alava E; de Torres C
    Br J Cancer; 2017 Sep; 117(6):767-774. PubMed ID: 28787430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes with nondose-dense chemotherapy for Ewing sarcoma: A practical approach for the developing world.
    Parambil BC; Vora T; Sankaran H; Prasad M; Bakshi A; Puri A; Gulia A; Qureshi S; Laskar S; Khanna N; Shah S; Ramadwar M; Kembhavi S; Chinnaswamy G; Banavali S
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28604. PubMed ID: 32706522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of bone and soft-tissue sarcomas registered during the year 2012 at Tata Memorial Hospital, Mumbai, with clinical outcomes.
    Bajpai J; Khanna N; Vora T; Gulia A; Laskar S; Puri A; Sanduptla B; Chinnaswamy G; Nayak P; Juvekar SL; Janu A; Desai S; Ghosh J; Purandare N; Ramadwar M; Rangarajan V; Rekhi B
    Indian J Cancer; 2018; 55(1):37-44. PubMed ID: 30147091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group.
    Cash T; McIlvaine E; Krailo MD; Lessnick SL; Lawlor ER; Laack N; Sorger J; Marina N; Grier HE; Granowetter L; Womer RB; DuBois SG
    Pediatr Blood Cancer; 2016 Oct; 63(10):1771-9. PubMed ID: 27297500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual sites of Ewing sarcoma (ES): a retrospective multicenter 30-year experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP) and Italian Sarcoma Group (ISG).
    Berger M; Fagioli F; Abate M; Riccardi R; Prete A; Cozza R; Bertulli R; Podda M; Ferrari S; Luksch R
    Eur J Cancer; 2013 Nov; 49(17):3658-65. PubMed ID: 23890769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of outcome and prognostic factors in extraosseous Ewing sarcoma.
    Biswas B; Shukla NK; Deo SV; Agarwala S; Sharma DN; Vishnubhatla S; Bakhshi S
    Pediatr Blood Cancer; 2014 Nov; 61(11):1925-31. PubMed ID: 25132242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a prognostic model for localized Ewing sarcoma family of tumors: A single institutional experience of 224 cases treated with uniform chemotherapy protocol.
    Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Mohanti BK; Sharma MC; Vishnubhatla S; Bakhshi S
    J Surg Oncol; 2015 May; 111(6):683-9. PubMed ID: 25557999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of post-induction resolution of pulmonary lesions in metastatic Ewing sarcoma.
    Halalsheh H; Kaste SC; Krasin MJ; Sykes A; Sahr N; Spunt SL; Federico SM; Bishop MW
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28150. PubMed ID: 31944574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine.
    Arshi A; Sharim J; Park DY; Park HY; Yazdanshenas H; Bernthal NM; Shamie AN
    Spine J; 2017 May; 17(5):645-655. PubMed ID: 27856382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adolescent-adult nonmetastatic Ewing sarcoma-Experience from a large developing country.
    Bajpai J; Panda GS; Chandrasekharan A; Bhargava P; Srinivas S; Laskar S; Dandekar S; Mokal S; Rekhi B; Khanna N; Menon N; Patil V; Noronha V; Joshi A; Prabhash K; Banavali SD; Gupta S
    Pediatr Blood Cancer; 2021 Sep; 68(9):e29081. PubMed ID: 33991401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
    Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patients.
    Iqbal N; Shukla NK; Deo SV; Agarwala S; Sharma DN; Sharma MC; Bakhshi S
    Clin Transl Oncol; 2016 Mar; 18(3):310-6. PubMed ID: 26243399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection.
    Pan HY; Morani A; Wang WL; Hess KR; Paulino AC; Ludwig JA; Lin PP; Daw NC; Mahajan A
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):349-57. PubMed ID: 25772182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.